About us
About Redenlab
Management team
Advisory board
Partners
What we do
Indications
Ataxia
Huntington’s Disease (HD)
Parkinson’s Disease
Alertness, Fatigue and Stress (AFS)
Frontotemporal Dementia (FTD)
Amyotrophic lateral sclerosis (ALS) / Motor Neurone Disease (MND)
Our technology
News & Publications
News
Events
Publications
Employment opportunities
Clinical Trial Solutions
Virtual trials
Redenlab’s recording solutions
Protocol design and development
Data analysis and interpretation
Quality control and assurance
Project management
Contact Us
Suite 669, 585 Little Collins Street
Melbourne VIC 3000 Australia
info@redenlab.com
Linkedin
About us
About Redenlab
Management team
Advisory board
Partners
What we do
Indications
Ataxia
Huntington’s Disease (HD)
Parkinson’s Disease
Alertness, Fatigue and Stress (AFS)
Frontotemporal Dementia (FTD)
Amyotrophic lateral sclerosis (ALS) / Motor Neurone Disease (MND)
Our technology
News & Publications
News
Events
Publications
Employment opportunities
Clinical Trial Solutions
Virtual trials
Redenlab’s recording solutions
Protocol design and development
Data analysis and interpretation
Quality control and assurance
Project management
Contact Us
Management team
Adam Vogel PhD
CEO / Chief Science Officer
View Profile
Angela Morgan PhD
Director of Pediatric / Neurodevelopment Communication
View Profile
Devon Borysiewicz
Vice President of Technology and Software Engineering
View Profile
Gustavo Noffs MD, PhD
Medical Director
View Profile
Geoff Stuart PHD
Director of Statistics
View Profile
Anthony Angwin PhD
Language Scientist
View Profile
Paul Maruff PhD
Chief Innovation Officer
View Profile
Gloria Macan
Director of Marketing and Communications
View Profile
Thayabaran Kathiresan
Director of Audio Engineering
View Profile
Arvind Tewari
Chief Operating Officer
View Profile
×
×